Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riviciclib (P276-00) with Radiation in Head and Neck Cancer
NCT00899054Phase 2Completed
- Sponsor
- Piramal Enterprises Limited
- Start
- Aug 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of P276 in head and neck squamous cell carcinoma (HNSCC), sponsored by Piramal Enterprises Limited. Started Aug 2009; status: completed.
02
Drugs
P276
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00899054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00899054.